Biological functions of nitric oxide

Global Nitric Oxide (NO) Market: Therapeutics, Drugs and Companies to 2028 - ResearchAndMarkets.com

Thursday, May 14, 2020 - 3:15pm

The report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.

Key Points: 
  • The report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.
  • Major segments of the market for nitric oxide-based drugs are described as well as the companies involved in developing them.
  • Nitric oxide (NO) can generate free radicals as well as scavenge them.
  • Another approach is modulation of nitric oxide synthase (NOS), which converts L-arginine to NO.

Steps to Avoid Illness from Infectious Diseases by Dr. Nathan S. Bryan: Nitric Oxide May Be the Key

Tuesday, April 28, 2020 - 1:33pm

Together, the data revealed that decreased nitric oxide production explains these findings.

Key Points: 
  • Together, the data revealed that decreased nitric oxide production explains these findings.
  • In fact, there are a number of clinical studies using inhaled nitric oxide in critically ill patients.However, we need nitric oxide prior to escalation of respiratory distress and need nitric oxide prior to hospitalization.
  • Furthermore, we need systemic increases in nitric oxide, not just in the airways and pulmonary circulation.
  • Steps to avoid illness from infectious disease:
    Increase your nitric oxide levels.

New Book Functional Nitric Oxide Nutrition Serves as a Preventive Guide to Treating Chronic Disease

Thursday, March 26, 2020 - 12:31pm

AUSTIN, Texas, March 26, 2020 /PRNewswire/ --Dr. Nathan Bryan, Ph.D., renowned expert on nitric oxide science, released his book,Functional Nitric Oxide Nutrition: Dietary Strategies to Prevent Chronic Disease,on one of the most important and mysterious molecules known to mankind: nitric oxide (NO).

Key Points: 
  • AUSTIN, Texas, March 26, 2020 /PRNewswire/ --Dr. Nathan Bryan, Ph.D., renowned expert on nitric oxide science, released his book,Functional Nitric Oxide Nutrition: Dietary Strategies to Prevent Chronic Disease,on one of the most important and mysterious molecules known to mankind: nitric oxide (NO).
  • This book is an accessible guide for medical professionals and consumers, offering up the newest scientific and medical information about nitric oxide.
  • "After 20 years of research and traveling the world to lecture and educate on nitric oxide, I realized that too few people knew about nitric oxide, including physicians and health care practitioners.
  • Bryan is an innovator of nitric oxide product technology and has recently developed the first and only nitric oxide based anti-aging skincare serum.

Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19

Wednesday, March 25, 2020 - 10:00am

(OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical field, today announced that the Company is closely monitoring two new clinical trials that are testing Nitric Oxide Gas Inhalation Therapy for the treatment of mild/moderate COVID-19.

Key Points: 
  • (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical field, today announced that the Company is closely monitoring two new clinical trials that are testing Nitric Oxide Gas Inhalation Therapy for the treatment of mild/moderate COVID-19.
  • In the past, inhaled nitric oxide (iNO) has been used as a supportive measure in treating patients infected with coronavirus (SARS-CoV) and exhibiting associated pulmonary complications.
  • We are watching the clinical trials closely for positive results in treatment of COVID-19.
  • Nu-Med Plus next-generation inhaled nitric oxide unit is currently available for use in research.

Nitric Oxide Industry Outlook to 2028 - Pathways, Physiology, Disease, Pharmacology, Therapeutic Applications, Drugs, Therapy Markets, Companies

Friday, March 13, 2020 - 11:30am

Major segments of the market for nitric oxide-based drugs are described as well as the companies involved in developing them.

Key Points: 
  • Major segments of the market for nitric oxide-based drugs are described as well as the companies involved in developing them.
  • Nitric oxide (NO) can generate free radicals as well as scavenge them.
  • It also functions as a signaling molecule and has an important role in the pathogenesis of several diseases.
  • Another approach is modulation of nitric oxide synthase (NOS), which converts L-arginine to NO.

Nitric Oxide Product Receives Overwhelming Response at A4M Anti-Aging Convention

Wednesday, February 19, 2020 - 2:36pm

As an international leader in molecular medicine and nitric oxide biochemistry, Dr. Bryan has devoted 20 years of research to the therapeutic use of nitric oxide to counter the effects of aging including cardiovascular disease.

Key Points: 
  • As an international leader in molecular medicine and nitric oxide biochemistry, Dr. Bryan has devoted 20 years of research to the therapeutic use of nitric oxide to counter the effects of aging including cardiovascular disease.
  • "Nitric oxide (NO) is one of the most important molecules produced by the human body."
  • Not only is Pneuma Nitric Oxide the first product of its kind, it is the first of what is becoming a revolution in the skin care industry.
  • Link to before and after images of clients using Pneuma Nitric Oxide Serum: https://app.box.com/s/sb7x1bhqt6gdlqfs1zfka4q6pn3voqnu
    Pneuma Nitric Oxide is a company focused on connecting beauty to wellness with Nitric Oxide-based technology and the highest caliber of ingredients.

Cyclerion announces IW-6463 phase 1 healthy volunteer study results that support further development for neurodegenerative diseases

Monday, January 13, 2020 - 12:00pm

IW-6463, a CNS-penetrant sGC stimulator, is being developed as a potentially disease modifying therapy for neurodegenerative diseases.

Key Points: 
  • IW-6463, a CNS-penetrant sGC stimulator, is being developed as a potentially disease modifying therapy for neurodegenerative diseases.
  • There are clear links between nitric oxide signaling defects and neurodegenerative diseases.
  • Evidence indicates that endothelial cell loss and nitric oxide dysregulation are contributors to neurodegenerative diseases and result in reduced blood flow, vascular leakage, inflammation, and neuronal dysfunction/loss.
  • For more information about Cyclerion, please visit https://www.cyclerion.com/ and follow us on Twitter ( @Cyclerion ) and LinkedIn ( www.linkedin.com/company/cyclerion ).

VERO Biotech, Leaders in the Development of Innovative Technologies for Inhaled Nitric Oxide Delivery, to Present at Biotech Showcase 2020

Friday, January 10, 2020 - 7:25pm

VERO Biotech recently received US Food and Drug Administration (FDA) approval of GENOSYL (nitric oxide) gas, for inhalation.

Key Points: 
  • VERO Biotech recently received US Food and Drug Administration (FDA) approval of GENOSYL (nitric oxide) gas, for inhalation.
  • Inhaled nitric oxide has revolutionized the treatment of PPHN, providing improved oxygenation and a reduced need for invasive extracorporeal membrane oxygenation.
  • Currently, the only way to provide inhaled nitric oxide is via large, pressurized gas cylinders and complicated delivery systems.
  • VERO Biotech LLC is dedicated to improving the lives of patients by leading the development of innovative technologies for inhaled nitric oxide delivery in the acute care hospital setting and beyond, wherever inhaled nitric oxide treatment is needed.

Patent filed for Nitric Oxide Delivery Device that is comparable to inhalers for single or short-term usage

Tuesday, January 7, 2020 - 11:00am

(OTCQB: NUMD), National Investment Bankers Association (NIBA) presenter Nu-Med Plus, Inc., a medical device development company announced that a patent has been filed for a nitric oxide delivery device that is designed for single or short-term use.

Key Points: 
  • (OTCQB: NUMD), National Investment Bankers Association (NIBA) presenter Nu-Med Plus, Inc., a medical device development company announced that a patent has been filed for a nitric oxide delivery device that is designed for single or short-term use.
  • Nitric oxide delivery devices on the market today are large, electronically complex devices that are used primarily in neonatal intensive care units.
  • The result was a simple mechanical device that delivers the appropriate dose of nitric oxide gas per inhalation to the patient.
  • Initial research and product development have been in the delivery of inhaled nitric oxide gas for therapeutic use.

Nu-Med Plus, Inc. Fast-Tracked Development Plan for Nitric Oxide Delivery Device Gaining Momentum

Wednesday, October 23, 2019 - 1:00pm

(OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the medical field, announces the production version of the nitric oxide delivery device for use in the neonatal intensive care unit(NICU) is anticipated to be delivered mid-December of this year.

Key Points: 
  • (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the medical field, announces the production version of the nitric oxide delivery device for use in the neonatal intensive care unit(NICU) is anticipated to be delivered mid-December of this year.
  • Initial research and product development has been in the delivery of inhaled nitric oxide gas for therapeutic use.
  • About Nu-Med Plus, Inc.: Nu-Med Plus, Inc. founded in 2011 is a medical device development company created to explore medical applications of newly developed nitric oxide technologies.
  • Initial research and product development has been in the delivery of inhaled nitric oxide gas for therapeutic use.